Hue University Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02614404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hue University of Medicine and Pharmacy | Hue University of Medicine and Pharmacy, Hue University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 4)

Kidney Diseases (Phase 4)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 10